Ambercrest Apiaries — Financial Plan & Projections

This section presents the full five-year financial plan: key assumptions, the funding structure and use of funds, and the three primary statements — projected profit & loss, balance sheet and cash flow — together with the supporting debt, working-capital and coverage analysis.…

Ambercrest Apiaries (Pty) Ltd Business PlanSection 14 › Financial Plan & Projections

Section 14 · Business Plan

Financial Plan & Projections

This section presents the full five-year financial plan: key assumptions, the funding structure and use of funds, and the three primary statements — projected profit & loss, balance sheet and cash flow — together with the supporting debt, working-capital and coverage analysis.…

Year 5 Revenue
ZAR 32.0 million

At a 35% Year-5 EBITDA margin, building from an early-stage loss to ZAR 6.2 million net profit after tax by Year 5.

This section presents the full five-year financial plan: key assumptions, the funding structure and use of funds, and the three primary statements — projected profit & loss, balance sheet and cash flow — together with the supporting debt, working-capital and coverage analysis. The sponsor’s headline revenue and EBITDA-margin guidance is preserved; everything below EBITDA is independently re-derived on a conservative, bankable basis.

14.1 Key modelling assumptions

Assumption Basis
Currency ZAR (USD at R18.3/USD for reference)
Corporate tax rate 27% (with assessed-loss carry-forward)
Senior debt rate 12.5% (prime 10.5% + 2.0% margin)
Revolver rate 13.5% (prime + 3.0%)
Debt tenor / grace 7 years / 12-month principal grace
Debtor / inventory / creditor days 45 / 55 / 30
Depreciation Straight-line: buildings 20y, hives 7y, plant 10y, packaging 8y, brand 5y
Exit assumption 5.0x EV/EBITDA trade sale at end Year 5
Revenue CAGR (Y1–Y5) ~59% (sponsor guidance, preserved)
EBITDA margin path 10% → 35% (sponsor guidance, preserved)

Table 25. Principal financial assumptions.

Honest-analyst note — the assumptions that matter most Two sponsor assumptions drive the outcome and are flagged as aggressive: a ~59% revenue CAGR and a 25-percentage-point EBITDA-margin expansion over five years. Both are preserved as the base case but stress-tested in Section 16. Interest rates reflect the SARB prime rate of 10.5% prevailing in mid-2026; a rising-rate environment would raise debt service and is captured in the downside scenario.

14.2 Funding structure and use of funds

The ZAR 18.0 million raise is split evenly between equity and senior debt, supported by a committed revolving working-capital facility and a funded debt-service reserve. This is a deliberately conservative structure for a biological-asset ramp.

Use of funds (ZAR m) Amount Share
Land 1.50 8%
Buildings & facilities 2.50 14%
Hives & colonies (2,000) 5.00 28%
Extraction & processing plant 3.00 17%
Packaging line 1.20 7%
Branding & intangibles 0.80 4%
DSRA (restricted) 1.00 6%
Initial working capital / cash 3.00 17%
Total 18.00 100%

Table 26. Use of the ZAR 18.0 million in funds.

Figure
Allocation Of The Zar 18.0 Million Raise Across Capital And Working Capital Uses. — visualised from the accompanying data.

Figure 8. Allocation of the ZAR 18.0 million raise across capital and working-capital uses.

Figure
Funding Structure: Equity And Senior Debt (50:50). — visualised from the accompanying data.

Figure 9. Funding structure: equity and senior debt (50:50).

14.3 Projected profit & loss

Revenue scales from ZAR 5.0m to ZAR 32.0m as the hive base and channel mix mature. The business records losses in Years 1–2 — driven by full depreciation and cash interest against a low early EBITDA — before turning profitable from Year 3, with net margin reaching roughly 19% by Year 5. Assessed losses from the ramp shelter early taxable profits.

Income statement (ZAR m) Y1 Y2 Y3 Y4 Y5
Revenue 5.0 10.0 18.0 25.0 32.0
Operating costs (4.5) (8.0) (13.0) (16.8) (20.8)
EBITDA 0.5 2.0 5.0 8.3 11.2
EBITDA margin 10% 20% 28% 33% 35%
Depreciation & amortisation (1.5) (1.6) (1.7) (1.9) (2.1)
EBIT (1.0) 0.4 3.3 6.3 9.1
Interest (term + revolver) (1.1) (1.1) (1.2) (1.0) (0.6)
Profit before tax (2.1) (0.7) 2.1 5.4 8.5
Taxation 0.0 0.0 0.0 (1.3) (2.3)
Net profit after tax (2.1) (0.7) 2.1 4.1 6.2
Net margin -42% -7% 12% 16% 19%

Table 27. Projected income statement, Years 1–5.

Figure
Year 5 Profit & Loss Cascade From Revenue To Net Profit (Zar Million). — visualised from the accompanying data.

Figure 10. Year-5 profit & loss cascade from revenue to net profit (ZAR million).

14.4 Projected balance sheet

The opening balance sheet is capitalised by the ZAR 18.0 million raise. Net property, plant & equipment declines gently as depreciation outpaces modest expansion capex, while retained earnings rebuild equity after the early losses. The balance sheet ties to zero in every year — enforced programmatically — and net debt deleverages from ZAR 7.8m to near-zero by Year 5.

Balance sheet (ZAR m) Y1 Y2 Y3 Y4 Y5
Assets
Net property, plant & equipment 12.8 12.3 11.6 10.9 10.0
Debt-service reserve (restricted) 1.0 1.0 1.0 1.0 1.0
Cash & equivalents 1.2 0.3 0.3 0.8 2.8
Accounts receivable 0.6 1.2 2.2 3.1 3.9
Inventory 0.7 1.2 2.0 2.5 3.1
Total assets 16.3 15.9 17.1 18.3 20.9
Equity & liabilities
Share capital 9.0 9.0 9.0 9.0 9.0
Retained earnings (2.1) (2.8) (0.7) 3.4 7.2
Total equity 6.9 6.2 8.3 12.4 16.2
Senior debt (non-current) 7.5 6.0 4.5 3.0 1.5
Senior debt (current) 1.5 1.5 1.5 1.5 1.5
Revolving facility 0.0 1.6 1.6 0.0 0.0
Accounts payable 0.4 0.7 1.1 1.4 1.7
Total equity & liabilities 16.3 15.9 17.1 18.3 20.9

Table 28. Projected balance sheet, Years 1–5 (ties to zero each year).

Figure
Balance Sheet Composition: Assets Versus Liabilities And Equity (Zar Million). — visualised from the accompanying data.

Figure 11. Balance-sheet composition: assets versus liabilities and equity (ZAR million).

14.5 Projected cash flow

Operating cash flow turns positive from Year 2 and grows strongly thereafter. Investing outflows are modest — reflecting self-funded, split-based hive expansion — while financing flows capture principal amortisation (from Year 2), revolver movements and dividends (from Year 4). The closing cash position, supported by the revolver in the ramp, never falls below the minimum operating buffer.

Cash flow (ZAR m) Y1 Y2 Y3 Y4 Y5
Operating cash flow (1.5) 0.0 2.6 4.9 7.2
Investing cash flow (0.3) (1.0) (1.1) (1.2) (1.2)
Financing cash flow 0.0 0.1 (1.5) (3.1) (4.0)
Net change in cash (1.8) (0.9) 0.0 0.5 2.0
Closing cash 1.2 0.3 0.3 0.8 2.8
of which: dividends paid 0.0 0.0 0.0 0.0 (2.5)
revolver outstanding (year-end) 0.0 1.6 1.6 0.0 0.0

Table 29. Projected cash flow statement, Years 1–5.

Figure
Cash Flow By Activity And Closing Cash Balance (Zar Million). — visualised from the accompanying data.

Figure 12. Cash flow by activity and closing cash balance (ZAR million).

14.6 Debt schedule and working capital

Senior debt & revolver (ZAR m) Y1 Y2 Y3 Y4 Y5
Term loan — opening 9.0 9.0 7.5 6.0 4.5
Term interest 1.1 1.1 0.9 0.8 0.6
Principal repaid 0.0 1.5 1.5 1.5 1.5
Term loan — closing 9.0 7.5 6.0 4.5 3.0
Revolver drawn (year-end) 0.0 1.6 1.6 0.0 0.0

Table 30. Senior debt amortisation and revolver utilisation.

Figure
Debt Outstanding And Net Debt To Ebitda Deleveraging. — visualised from the accompanying data.

Figure 13. Debt outstanding and net-debt-to-EBITDA deleveraging.

Working capital is sized on 45 debtor days, 55 inventory days and 30 creditor days. Net working capital grows with revenue and is the primary call on the revolving facility during the ramp.

Working capital (ZAR m) Y1 Y2 Y3 Y4 Y5
Accounts receivable 0.6 1.2 2.2 3.1 3.9
Inventory 0.7 1.2 2.0 2.5 3.1
Accounts payable (0.4) (0.7) (1.1) (1.4) (1.7)
Net working capital 0.9 1.8 3.1 4.2 5.4

Table 31. Net working-capital build.

14.7 Revenue driver assumptions

The headline revenue path is underpinned by the explicit pricing and volume drivers below, held at conservative, inflation-consistent levels. Honey prices escalate roughly 5% per year; pollination fees track the WCBA/SABIO guideline; per-hive yields sit at the low end of the industry range to reflect the pollination trade-off.

Driver Year 1 Year 5 Basis / source
Retail honey price (R/kg) ~200 ~243 Premium retail, ~5%/yr escalation
Bulk honey price (R/kg) ~95 ~115 Manufacturer offtake pricing
Export honey price (R/kg) ~165 ~200 FOB premium, hard-currency linked
Honey yield (kg / productive hive) 20 26 Conservative vs 20–30 kg industry range
Pollination fee (R / placement) 1,450 1,760 WCBA/SABIO guideline, escalated
Pollination placements ~1,100 ~2,000 Western Cape orchard contracts

Table 32. Principal revenue drivers (consistent with the financial model).

This document contains proprietary and confidential information. Distribution without written consent is prohibited.